Latest Features & Opinion

Coverage of CMSC 2018

Follow Neurology Advisor for live coverage of research being presented at the 2018 Annual Meeting of the Consortium of Multiple Sclerosis Centers, May 30-June 2, 2018 in Nashville.

Time Matters In MS: Expert Q&A

In April 2018, the American Academy of Neurology released updated guidelines for the treatment of multiple sclerosis (MS). The new recommendations are based on a panel review of 20 Cochrane reviews and 73 full-text articles pertaining to starting, switching, and stopping disease-modifying treatment in patients with clinically isolated syndrome, relapsing-remitting MS, and progressive forms of MS.

Emerging Innovations in Parkinson Disease Treatment

Surgical interventions for Parkinson disease are experiencing a swell in innovation, thanks in part to the entry of two additional medical device companies into a field previously dominated by one company.

Addressing Migraine That Mimics Stroke

Neurology Advisor spoke with Dr Peter McAllister about how to best discern migraine with aura from stroke.

Diagnosing, Treating CNS Fungal Infections

While immunocompromised patients are the most susceptible to CNS fungal infections, they can also occur in immunocompetent patients undergoing invasive procedures such as neurosurgery and in patients exposed to contaminated devices or drugs.

The Evolution of NEDA

Each component of NEDA has limitations — for example, measures of brain atrophy may be confounded by various factors, and the correlation between short-term measures of EDSS progression and long-term disability outcomes is unclear.

Managing Neurological Manifestations of Sjogren Syndrome

Experts discuss the symptoms and prevalence of neurological manifestations in Sjogren syndrome.

The Consequences of Compensation in Autism

Although compensating for their difficulties may help people with ASD connect with others, get jobs, and successfully navigate social situations, accumulating research suggests it can also lead to exhaustion, burnout, anxiety, and depression.

Headache in Older Adults: Unique Causes ...

It is important for clinicians to quickly and accurately determine potential underlying causes and to prescribe treatments that take into account comorbidities and medications that older patients may be taking for them.

Strategies for Improved Seizure Reporting

Before we begin to rely more heavily on technology for seizure detection, clinician-patient trust needs to improve.

Respiratory Muscle Training in Multiple Sclerosis

Early intervention in the case of respiratory compromise in patients with multiple sclerosis has the potential to prevent infection and maintain pulmonary function.
Navigating the Waters of Medical Malpractice and Defensive Medicine

Navigating the Waters of Medical Malpractice and Defensive Medicine

Malpractice liability reform would best be analyzed on a specialty-by-specialty basis.

FOR YOUR PRACTICE

Practice Management

The Little Guy vs Big Data: Is ICD-10 Coding Still Valuable in Health Care?

The Little Guy vs Big Data: Is ICD-10 Coding Still Valuable in Health Care?

While ICD-10-CM may be an improvement on an old process, big data is the revolution that has the potential to change health care forever.

Drug Lookup

Search our drug information database which contains an extensive list of neurologic drugs.

Browse drugs by:

Brand Generic Disease

Latest in Autism Spectrum Disorder

Some Common Allergies Linked to Odds of Autism in Children

Common allergic conditions, especially food allergy, are associated with autism spectrum disorder in children.

Much International Consensus Regarding Employment in Autism

There is international consensus as to the importance of work experience and vocational training for helping individuals with ASD obtain employment.

FDA Fast-Tracks Treatment for Autism Spectrum Disorder

There are currently no approved pharmacological treatments that address these core symptoms of ASD.

Latest in Neuromuscular Disorders

Immunotherapy Promising for Slowing Progression of ALS

A new immunotherapy appears to be well tolerated and possibly of benefit in patients with amyotrophic lateral sclerosis.

Eculizumab May Improve Independent Walking Ability in Guillain-Barré Syndrome

High-dose intravenous immunoglobulin therapy was administered to all patients and may have contributed to neutralization of eculizumab.

Facioscapulohumeral Muscular Dystrophy Treatment Gets Fast Track Status

ACE-083 is currently being studied in a Phase 2 trial for FSHD and another for Charcot-Marie-Tooth (CMT) disease.

Sign Up for Free e-newsletters



CME Focus